Profit Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Profit Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,596	Closed	-$466K	–	88
2017 Q3	$466K	Buy	4,596 +2,181	+90%	+$234K	0.41%	67
2017 Q2	$242K	Sell	2,415 -5,821	-71%	-$626K	0.22%	90
2017 Q1	$996K	Sell	8,236 -5,551	-40%	-$681K	0.81%	52
2016 Q4	$1.54M	Buy	13,787 +4,848	+54%	+$584K	1.46%	21
2016 Q3	$1.19M	Buy	8,939 +6,103	+215%	+$583K	1.17%	33
2016 Q2	$260K	Buy	+2,836	New	+$239K	0.21%	94

Other funds holding GWPH

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Profit Investment Management's GWPH Position: Q4 2017 in Review

Profit Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 4,596 shares — an estimated $466K sold.

Profit Investment Management first reported a position in GWPH in Q2 2016 and held it in 6 quarters. The position peaked at $1.54M in Q4 2016. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

Profit Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
Profit Investment Management sold 4,596 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $466K.
Profit Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 6 quarters.
Profit Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.54M in Q4 2016.
204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on Profit Investment Management's 13F filing for Q4 2017, filed 17 Jan 2018.